company background image
CMOTEC B logo

Scandinavian ChemoTech OM:CMOTEC B Stock Report

Last Price

SEK 1.47

Market Cap

SEK 34.3m

7D

0%

1Y

-41.7%

Updated

24 Dec, 2024

Data

Company Financials +

Scandinavian ChemoTech AB (publ)

OM:CMOTEC B Stock Report

Market Cap: SEK 34.3m

CMOTEC B Stock Overview

Offers cancer care and pain management solutions in Sweden. More details

CMOTEC B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Revenue is forecast to grow 60.72% per year

Risk Analysis

Does not have a meaningful market cap (SEK34M)

Has less than 1 year of cash runway

Makes less than USD$1m in revenue (SEK5M)

Shareholders have been diluted in the past year

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Scandinavian ChemoTech AB (publ) Competitors

PolarCool

NGM:POLAR

SEK 35.8m

Carbiotix

NGM:CRBX

SEK 49.8m

Zenicor Medical Systems

NGM:ZENI

SEK 26.9m

Prolight Diagnostics

NGM:PRLD

SEK 90.6m

Price History & Performance

Summary of share price highs, lows and changes for Scandinavian ChemoTech
Historical stock prices
Current Share PriceSEK 1.47
52 Week HighSEK 5.20
52 Week LowSEK 1.23
Beta1.33
1 Month Change-16.00%
3 Month Change-35.53%
1 Year Change-41.67%
3 Year Change-91.01%
5 Year Change-88.86%
Change since IPO-97.27%

Recent News & Updates

Recent updates

Shareholder Returns

CMOTEC BSE Medical EquipmentSE Market
7D0%2.0%-2.0%
1Y-41.7%-7.7%4.4%

Return vs Industry: CMOTEC B underperformed the Swedish Medical Equipment industry which returned -7.7% over the past year.

Return vs Market: CMOTEC B underperformed the Swedish Market which returned 4.4% over the past year.

Price Volatility

Is CMOTEC B's price volatile compared to industry and market?
CMOTEC B volatility
CMOTEC B Average Weekly Movement9.8%
Medical Equipment Industry Average Movement7.0%
Market Average Movement5.6%
10% most volatile stocks in SE Market11.4%
10% least volatile stocks in SE Market3.2%

Stable Share Price: CMOTEC B's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: CMOTEC B's weekly volatility has decreased from 15% to 10% over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
20135Stefan Frickchemotech.se

Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden. The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses.

Scandinavian ChemoTech AB (publ) Fundamentals Summary

How do Scandinavian ChemoTech's earnings and revenue compare to its market cap?
CMOTEC B fundamental statistics
Market capSEK 34.32m
Earnings (TTM)-SEK 15.70m
Revenue (TTM)SEK 5.03m

6.8x

P/S Ratio

-2.2x

P/E Ratio

Is CMOTEC B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CMOTEC B income statement (TTM)
RevenueSEK 5.03m
Cost of RevenueSEK 2.02m
Gross ProfitSEK 3.01m
Other ExpensesSEK 18.71m
Earnings-SEK 15.70m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 04, 2025

Earnings per share (EPS)-0.67
Gross Margin59.88%
Net Profit Margin-311.96%
Debt/Equity Ratio0%

How did CMOTEC B perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 04:11
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Scandinavian ChemoTech AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sebastian AnderssonRedeye
Martin WahlstromRedeye